Cancer Treatment News and Research

RSS

AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system

AlderMed announced today it has entered into a three-year exclusive distribution agreement with Gulmay Medical, manufacturer of the Xstrahl-100 therapy system.

From Xstrahl 30 Apr 2012

MCC researchers aim to improve cancer patient's quality of life and care

Researchers at Moffitt Cancer Center have placed new emphasis on gathering data on cancer patient quality of life during both treatment and survivorship. Their focus is on gathering and using that data to develop interventions to improve the quality of life for patients in treatment and for cancer survivors.

30 Apr 2012

Accuray launches Prostate Advances in Comparative Evidence Study

Accuray Incorporated, the premier radiation oncology company, announced today the launch of the Prostate Advances in Comparative Evidence (PACE) Study, an international, multi-center, randomized study to compare CyberKnife® Stereotactic Body Radiation Therapy (SBRT), da Vinci assisted and manual laparoscopic surgery and conventionally fractionated intensity modulated radiation therapy (IMRT), for the treatment of localized prostate cancer.

27 Apr 2012

Irreversible Electroporation can more effectively kill cancer cells with BNNTs

A new study has shown that adding boron-nitride nanotubes to the surface of cancer cells can double the effectiveness of Irreversible Electroporation, a minimally invasive treatment for soft tissue tumors in the liver, lung, prostate, head and neck, kidney and pancreas.

27 Apr 2012

Robot assisted laparoscopic radical prostatectomy better than other surgical techniques

Outcomes from use of a robot to assist surgeons in removal of a cancerous prostate are at least as good, if not better, than the other two techniques used for a radical prostatectomy -- open or laparoscopic surgery -- according to a large meta analysis led by researchers at NewYork-Presbyterian/Weill Cornell.

26 Apr 2012

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, and PLUS Diagnostics today announced that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer test in the United States.

26 Apr 2012

Scientists discover tumor-targeting neural stem cells

Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.

21 Apr 2012

Patients with head and neck cancer can benefit from swallowing exercises

Mount Sinai School of Medicine researchers have found that targeted swallowing exercises can help alleviate swallowing dysfunction - a debilitating side effect in people undergoing chemoradiation therapy (CRT) for head and neck cancer.

20 Apr 2012

Cholesterol may slow or stop cancer cell growth

A Simon Fraser University researcher is among four scientists who argue that cholesterol may slow or stop cancer cell growth. They describe how cholesterol-binding proteins called ORPs may control cell growth in A Detour for Yeast Oxysterol Binding Proteins, a paper published in the latest issue of the Journal of Biological Chemistry.

20 Apr 2012

Breast cancer treatment and classification revolutionized in landmark study

Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.

19 Apr 2012

New studies on personalized lung cancer treatment presented at 3rd ELCC

Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.

19 Apr 2012

Global summit on international breast health to take place from Oct. 3-5

Supportive care and quality-of-life issues should be considered essential elements of a multidisciplinary approach to breast cancer treatment at the point of breast cancer diagnosis. However, for women suffering from breast cancer in low- and middle-resource countries and other medically underserved areas around the world, this fundamental area of patient care generally is neglected and misunderstood.

19 Apr 2012

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.

18 Apr 2012

Innovative model of breast cancer rehabilitation

The Prospective Surveillance Model, an innovative new model of breast cancer rehabilitation, is featured in a special supplement to the American Cancer Society's journal, Cancer released on April 6, 2012. The model addresses the numerous physical issues faced by women with breast cancer and offers hope for an improved quality of life for all women with breast cancer through rehabilitation and exercise.

18 Apr 2012

High intensity focused ultrasound to treat prostate cancer shows initial success

A new tumor treatment that involves heating it with highly focused ultrasound, may mean men with prostate tumors can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies.

17 Apr 2012

More than one third of patients with invasive cancer are undertreated for their pain

More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive analgesics, according to research from The University of Texas MD Anderson Cancer Center.

17 Apr 2012

Physical activity reduces depression, enhances QOL during treatment for breast cancer

Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.

16 Apr 2012

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

Autism is an extremely complex diagnosis. Parental insight, physician observations and hours of data can factor into determining whether a child actually has the condition or is just a little on the quirky side. Now a Harvard researcher, Dennis P. Wall, has published research about a Web-based tool he developed that promises to diagnose autism in minutes, not hours -;

12 Apr 2012

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

A new image-guided radiotherapy system will be dedicated on Thurs., April 19, 2012 at DMC Huron Valley-Sinai Hospital. The TrueBeam system treats cancer more effectively through highly precise targeting of lung, breast, prostate, and head and neck tumors.

12 Apr 2012

Majority of Michigan oncology practices follow treatment guidelines for common cancers

A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.

11 Apr 2012

Cancer Treatment News and Research

AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system

MCC researchers aim to improve cancer patient's quality of life and care

Accuray launches Prostate Advances in Comparative Evidence Study

Irreversible Electroporation can more effectively kill cancer cells with BNNTs

Robot assisted laparoscopic radical prostatectomy better than other surgical techniques

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

Scientists discover tumor-targeting neural stem cells

Patients with head and neck cancer can benefit from swallowing exercises

Cholesterol may slow or stop cancer cell growth

Breast cancer treatment and classification revolutionized in landmark study

New studies on personalized lung cancer treatment presented at 3rd ELCC

Global summit on international breast health to take place from Oct. 3-5

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

Innovative model of breast cancer rehabilitation

High intensity focused ultrasound to treat prostate cancer shows initial success

More than one third of patients with invasive cancer are undertreated for their pain

Physical activity reduces depression, enhances QOL during treatment for breast cancer

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

Majority of Michigan oncology practices follow treatment guidelines for common cancers

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News